Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...

Pfizer (NYSE:PFE) shares rose more than 1% at the start of trading on Tuesday after the drugmaker hiked full-year guidance and reported better-than-expected Q2 earnings and revenue. The company’s ...

Pfizer reports Q2 earnings of 60 cents per share, beating 46 cents estimate Full-year revenue forecast raised to $59.5-$62.5 billion range Company targets $4 billion in cost savings by end of 2024 ...

Pfizer (NYSE: PFE) shares rose more than 1% at the start of trading on Tuesday after the drugmaker hiked full-year guidance and reported better-than-expected Q2 earnings and revenue.

Pfizer stays the course on 2024 outlook after delivering better earnings than Wall Street forecast. TOM ... New York. Pfizer reports their earnings on Tuesday, Jan ... Motors’s Q2 Sales Results ...

Pfizer (PFE) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.67 per share a year ago. These figures ...

Pfizer (PFE) delivered earnings and revenue surprises of 10.31% and 8.21%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Pfizer (PFE) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.07 per share a year ago. These figures are ...

Pfizer (PFE) delivered earnings and revenue surprises of 19.64% and 2.03%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Pfizer also hiked its revenue outlook to a range of $59.5 billion to $62.5 billion, ... Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs ...

Pfizer (PFE) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $0.78 per share a year ago.